UPDATE: Morgan Stanley Initiates Coverage on Bruker Ahead of Expected Margin Expansion

In a report published Wednesday, Morgan Stanley analyst Daniel Brennan initiated coverage on Bruker Corporation (NASDAQ: BRKR ) with an Overweight rating and $23.00 price target. In the report, Morgan Stanley noted, “BRKR has a strong, technology oriented, analytical instrument franchise where mgmt historically focused almost exclusively on top line